Condensed Consolidated Statements of Changes in Shareholders' Equity (Unaudited) - USD ($)	Common Stock [Member]	Additional Paid-in Capital [Member]	Subscription Receivable [Member]	Retained Earnings [Member]	AOCI Attributable to Parent [Member]	Total
Balance at Dec. 31, 2023	$ 152	$ 100,843,091	$ (1,817,640)	$ (96,499,518)	$ (569,749)	$ 1,956,336
Balance, shares at Dec. 31, 2023	15,219
Issuance of common shares for exercise of warrants	$ 109	2,676,871				2,676,980
Issuance of common shares for exercise of warrants, shares	10,856
Stock-based compensation		351,488				351,488
Foreign exchange translation gain					17,906	17,906
Net loss				(2,456,915)		(2,456,915)
Common Stock sold under the Equity Distribution Agreement, net of offering costs of $583,713	$ 93	1,808,696				1,808,789
Common Stock sold under the Equity Distribution Agreement, net of offering costs of $583,713, shares	9,267
Issuance of direct offering shares	$ 13	322,440				322,453
Issuance of direct offering shares, shares	1,271
Proceeds from the subscription receivable related to the issuance of Inducement Warrants, net of offering costs of $12,821		(12,821)	280,500			267,679
Proceeds from the subscription receivable related to the exercise of warrants and preferred investment options and issuance of Common Stock in abeyance	$ 39	(39)	1,537,140			1,537,140
Proceeds from the subscription receivable related to the exercise of warrants and preferred investment options and issuance of Common Stock in abeyance, shares	3,912
Balance at Mar. 31, 2024	$ 406	105,989,726		(98,956,433)	(551,843)	6,481,856
Balance, shares at Mar. 31, 2024	40,525
Balance at Dec. 31, 2023	$ 152	100,843,091	(1,817,640)	(96,499,518)	(569,749)	1,956,336
Balance, shares at Dec. 31, 2023	15,219
Foreign exchange translation gain						34,751
Net loss						(6,420,341)
Balance at Sep. 30, 2024	$ 500	107,405,507		(102,919,859)	(534,998)	3,951,150
Balance, shares at Sep. 30, 2024	49,977
Balance at Mar. 31, 2024	$ 406	105,989,726		(98,956,433)	(551,843)	6,481,856
Balance, shares at Mar. 31, 2024	40,525
Issuance of common shares for vested RSU
Issuance of common shares for vested RSU, shares	9
Stock-based compensation		369,614				369,614
Foreign exchange translation gain					(14,652)	(14,652)
Net loss				(1,879,394)		(1,879,394)
Issuance of direct offering shares	$ 25	448,815				448,840
Issuance of direct offering shares, shares	2,545
Common Stock sold under the Purchase Agreement, net of offering costs	$ 7	(7)
Common Stock sold under the Purchase Agreement, net of offering costs, shares	695
Balance at Jun. 30, 2024	$ 438	106,808,148		(100,835,827)	(566,495)	5,406,264
Balance, shares at Jun. 30, 2024	43,774
Issuance of common shares for vested RSU	$ 1	(1)
Issuance of common shares for vested RSU, shares	144
Stock-based compensation		369,614				369,614
Foreign exchange translation gain					31,497	31,497
Net loss				(2,084,032)		(2,084,032)
Common Stock sold under the Purchase Agreement, net of offering costs	$ 61	227,746				227,807
Common Stock sold under the Purchase Agreement, net of offering costs, shares	6,059
Balance at Sep. 30, 2024	$ 500	107,405,507		(102,919,859)	(534,998)	3,951,150
Balance, shares at Sep. 30, 2024	49,977
Balance at Dec. 31, 2024	$ 565	108,261,264		(106,074,505)	(594,517)	1,592,807
Balance, shares at Dec. 31, 2024	56,501
Issuance of Common Stock and Series A and B and prefunded warrants for cash, net of offering costs of $755,487	$ 1,024	4,243,443				4,244,467
Issuance of Common Stock and Series A and B and prefunded warrants for cash, net of offering costs of $755,487, shares	102,444
Issuance of common shares for vested RSU	$ 12	(12)
Issuance of common shares for vested RSU, shares	1,215
Issuance of common shares for exercise of warrants	$ 385	74,659				75,044
Issuance of common shares for exercise of warrants, shares	38,528
Issuance of round up shares	$ 73	(73)
Issuance of round up shares, shares	7,283
Stock-based compensation		193,848				193,848
Foreign exchange translation gain					(3,487)	(3,487)
Net loss				(2,184,966)		(2,184,966)
Balance at Mar. 31, 2025	$ 2,059	112,773,129		(108,259,471)	(598,004)	3,917,713
Balance, shares at Mar. 31, 2025	205,971
Balance at Dec. 31, 2024	$ 565	108,261,264		(106,074,505)	(594,517)	1,592,807
Balance, shares at Dec. 31, 2024	56,501
Foreign exchange translation gain						13,572
Net loss						(6,577,816)
Balance at Sep. 30, 2025	$ 5,183	116,684,259		(112,652,321)	(580,945)	3,456,176
Balance, shares at Sep. 30, 2025	518,296
Balance at Mar. 31, 2025	$ 2,059	112,773,129		(108,259,471)	(598,004)	3,917,713
Balance, shares at Mar. 31, 2025	205,971
Stock-based compensation		206,260				206,260
Foreign exchange translation gain					24,473	24,473
Net loss				(2,519,181)		(2,519,181)
Issuance of common shares for cash pursuant to ATM Agreement, net of offering costs	$ 462	555,042				555,504
Issuance of common shares for cash pursuant to ATM Agreement, net of offering costs, shares	46,197
Balance at Jun. 30, 2025	$ 2,521	113,534,431		(110,778,652)	(573,531)	2,184,769
Balance, shares at Jun. 30, 2025	252,168
Issuance of common shares for exercise of warrants	$ 2,021	1,882,193				1,884,214
Issuance of common shares for exercise of warrants, shares	202,083
Stock-based compensation		186,981				186,981
Foreign exchange translation gain					(7,414)	(7,414)
Net loss				(1,873,669)		(1,873,669)
Issuance of common shares for cash pursuant to ATM Agreement, net of offering costs	$ 641	1,080,654				1,081,295
Issuance of common shares for cash pursuant to ATM Agreement, net of offering costs, shares	64,045
Deemed dividend on inducement of warrants of $1,513,449
Balance at Sep. 30, 2025	$ 5,183	$ 116,684,259		$ (112,652,321)	$ (580,945)	$ 3,456,176
Balance, shares at Sep. 30, 2025	518,296